EMA Guidance on Trial Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.
Related Education Resources.
All Resources2018 GCSG US Conference Recap Video
Topic: Conference
Video
Members
Navigating Regulatory and QA Challenges in Clinical Supply Management
Topic: Regulatory
Executive Summary
Members
COVID-19’s Impact on the Supply Chain in Asia-Pacific
Topics: COVID-19, Supply Chain
Webinar
Free
